Randomized Phase III Study of Ganetespib, a Heat Shock...

  • Main
  • 2019 / 12
  • Randomized Phase III Study of Ganetespib, a Heat Shock...

Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non–Small-Cell Lung Cancer (GALAXY-2)

Pillai, Rathi N., Fennell, Dean A., Kovcin, Vladimir, Ciuleanu, Tudor-Eliade, Ramlau, Rodryg, Kowalski, Dariusz, Schenker, Michael, Yalcin, Ilker, Teofilovici, Florentina, Vukovic, Vojo M., Ramalingam
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.19.00816
Date:
December, 2019
File:
PDF, 743 KB
2019
Conversion to is in progress
Conversion to is failed